Wednesday, June 20, 2018
Company News: Page (1) of 1 - 12/07/17 Email this story to a friend. email article Print this page (Article printing at page facebook
World Unnatural Amino Acids Market Ultimate Growth at CAGR of 7.4% Expected by 2023

(December 07, 2017)

"Market Research Future"
The Global Unnatural Amino Acids Market report explores increasing competition among existing market players. The report gives increasing demand for better treatment and rising number of patients suffering from chronic diseases such as liver diseases, and inflammatory diseases are likely to provide support for the growth of the market.

The Worldwide Unnatural Amino Acids Market Increasing demand for unnatural amino acids for the development of finished pharmaceutical products, increasing research and development activities in pharmaceuticals and manufacturing of active pharmaceutical industry drive the growth of the market.

Unnatural amino acids are a chemically synthesized or naturally occurring non-proteinogenic amino acids. A large number of amino acid derivatives are used as building blocks or primary ingredients for a number of pharmaceutical compounds, which act as molecular scaffolds in various pharmaceutical products. They are molecular scaffolds or pharmacologically active products and have diverse structural elements that lead to the development of new peptide and non-peptide compounds having a number of applications in the chemical industry as well as pharmaceuticals industry.

Exclusive Sample Copy @ .

The Global Unnatural Amino Acids Market is segmented on the basis of types, indication, and end users.

On the basis of THE types, the market is segmented into non-alpha, D-Amino Acids, L-Amino Acid, and others. The non-alpha type is further segmented into ▀-amino acids, ▀-amino acid derivatives, ?-aminobutyric acid, and others. D-Amino Acids is further segmented into D-alanine, D-glutamate, and others.

On the basis of the indication, the market is segmented into liver diseases, cancer, genetic diseases, inflammatory disease, and others.

On the basis of the end users, the market is segmented into pharmaceutical & biotechnological companies, hospital & clinics, academic institutes, and others.

Some of key the players in the market are Merck KGaA (Germany), CordenPharma International (Germany), YONEYAMA YAKUHIN KOGYO CO.,LTD.á (Japan), Sekisui XenoTech, LLC. (U.S.) , Varsal (U.S.), Biosyn (U.S.), NAGASE & CO., LTD. (Japan), Kyowa Hakko Europe GmbH, AbbVie, Inc. (U.S.), Ajinomoto Co., Inc. (Japan), AminoLogics Co. Ltd. (South Korea), AnaSpec, Inc. (U.S.), BASF SE (Germany), Biological E Ltd. (India), C-TRI Co., Ltd. (South Korea), and Evonik Industries AG (Germany), Divis Laboratories Ltd. (India), Donboo Amino Acid Co., Ltd. (China), DSM Sinochem Pharmaceuticals (Singapore), EMD Millipore (USA), Enzo Life Sciences, Inc. (USA), Evonik Industries AG (Germany), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), Pfizer, Inc. (the USA), Ranbaxy Laboratories Ltd. (India), and Sanofi (France).

Major TOC for Unnatural Amino Acids Market:

  1. 1. Report Prologue

    Page: 1

    Related Keywords:Business,Health & Medicine,Science,U.S,World,
    Related Sites: DMN Newswire ,   HTN - Health Technology Net
    Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines